Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Alexandria Venture Investments

Status
ACTIVE
Global HQ
Pasadena, United States
Countries of investment
  • United States
Investment stages
  • Seed
  • Series B
  • Growth
Industries
  • Diagnostics
  • Agtech
  • Technology
About
Alexandria Venture Investments is the strategic corporate venture arm of Alexandria Real Estate Equities, investing in disruptive life science companies while developing innovation clusters that improve human health.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Alexandria Venture Investments is the strategic VC arm of Alexandria Real Estate Equities, investing in disruptive life sciences, agrifoodtech, climate tech, and related platforms to advance human health. As the most active corporate investor in biopharma for multiple consecutive years, it supports early to growth stage companies while reinforcing its life science real estate ecosystem through insight, capital, and cluster-based collaboration.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Alexandria Venture Investments, the strategic arm of Alexandria Real Estate Equities, positions itself as a long-term partner in life sciences clusters, though public profiles of its managers’ individual experience are limited.

Portfolio

Polaris Partners

Versant Ventures

and Alexandria Venture Investments have portfolio companies including Trulia

Datadog

Jazz Pharmaceuticals

CRISPR Therapeutics

Maze Therapeutics

Umoja Biopharma

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp